Fellow in Consumer Policy Studies Michelle Minton breaks down the FDA’s behind-the-scenes push to regulate dietary supplements nearly as strictly as prescription drugs.
February 2, 2012: The FDA's Latest Power Grab [4:55m]: Play Now | Play in Popup | Download (7)
…
Senior Fellow Greg Conko breaks down the fight over Avastin, a drug used to treat several types of cancer. The FDA is poised to rescind Avastin’s approval for treating breast cancer. It will retain its approval for other cancers. This will…
May 31, 2011: FDA Rescinds Approval of Breast Cancer Drug [7:55m]: Play Now | Play in Popup | Download (481)
CEI Senior Fellow Greg Conko looks at the major provisions of the food safety bill that the Senate is voting on today. The bill would set in stone ever-evolving best practices. Changes to plant inspection and food recall policies are a…
Richard Morrison and Marc Scribner welcome new media guru Brooke Oberwetter to the show to discuss the latest developments in the net neutrality battle, Minneapolis’ failures in urban planning, the FDA’s desire to regulate e-cigarettes, and legalizing Internet gambling.
Episode 105 [21:04m]: Play Now |…
Your host Richard Morrison and guest co-hosts William Yeatman and Ryan Young conspire to bring you episode 64. We start with the big vote on health care legislation, squeezing more energy from the ground and the warming that wasn’t there. We continue with the…
This week, your host Richard Morrison and special guest host William Yeatman talk through the Progress and Freedom Foundation’s technology summit in Aspen, the oil connection to Russia’s invasion of Georgia, hope for reform at the Food and Drug Administration and…
Episode 4: Oil Addiction, A Disturbing Trend Amongst Teens [27:26m]: Play Now | Play in Popup | Download (226)CEI’s Richard Morrison and Cord Blomquist discuss the housing bailout, Ted Stevens’ indictment, Comcast vs. the FCC, nanotech fears, hope for reform at the Food and Drug Administration, a get-well-soon wish for Robert Novak and the Milton Friedman legacy. Also,…
